Global Triamcinolone Acetonide Cream Market Size, Share and Trends Analysis Report, By Type (0.025%, 0.1%, and 0.5%), By Application (Eczema, Psoriasis, Dermatitis, and Others), and By Distribution Channel (Hospitals, Drug Stores, and Others), Forecast 2022-2028

The global triamcinolone acetonide cream market is anticipated to grow at a significant CAGR during the forecast period 2022-2028. The growth of the market is attributed to the rising cases of eczema, psoriasis, and dermatitis globally. According to National Eczema Association (NEA), 31.6 million approximately 10.1% of people in the US have some form of eczema. Approximately 9.6 million US children under the age of 18 have atopic dermatitis. An estimated 16.5 million US adults have an AD that initially began at 2 years of age, with nearly 40% affected by moderate or severe disease. According to the American Academy of Dermatology (AAD), approximately 7.5 million people in the US have psoriasis. It occurs in all age groups but is primarily seen in adults, with the highest proportion between ages 45 and 65. Approximately 25-30% of people with psoriasis experience joint inflammation that produces symptoms of arthritis. The growing demand for the treatment of these infectious diseases is propelling the growth of the market. There is a surge in demand for topical corticosteroids such as triamcinolone acetonide.

Increasing cases of infectious skin diseases such as eczema, dermatitis, and psoriasis among others is considered to be the primary factor bolstering the growth of the market over the forecast period. According to the World Health Organization (WHO), in 2019, around 1 in 5 children are suffering from atopic dermatitis (AD) also known as eczema in India. Additionally, eczema affects males and females equally, however, it is more common in people with personal or family history of asthma, environmental allergies, and food allergies. Triamcinolone acetonide is a topical corticosteroid that is used to treat yeast infections on the skin.

Some major players in the market include G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc., and Teva Pharmaceutical Industries Ltd. among others. The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in February 2019, Strides Pharma Science Ltd. stepped‐down its wholly owned subsidiary, Strides Pharma Global Pte. Ltd. based in Singapore. The company has received approval for Triamcinolone Acetonide Cream USP, 0.025%, 0.1% and 0.5%. from the US Food & Drug Administration (USFDA). The product is a generic version of Triamcinolone Acetonide Cream developed by Mylan Pharmaceuticals Inc.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- G&W laboratories Inc., Lannett Co. Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Triamcinolone Acetonide Cream Market Report by Segment

By Type

• 025%
• 1%
• 5%

By Application

• Eczema
• Psoriasis
• Dermatitis
• Others

By Distribution Channel

• Hospitals
• Drug Stores
• Others

Global Triamcinolone Acetonide Cream Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa